Literature DB >> 1728072

Evaluation and surgical correction of esophagitis after partial gastrectomy.

D C Gotley1, D E Ball, R W Owen, R C Williamson, M J Cooper.   

Abstract

Among 51 patients with refractory symptomatic reflux esophagitis seen during an 18-month period, 8 (16%) had undergone previous partial gastrectomy. Either Billroth II (n = 6) or Billroth I (n = 2) resection had been carried out for peptic ulceration 18 months to 30 years beforehand. Each patients was evaluated by symptom scoring, endoscopy, and 24-hour pH monitoring plus a 16-hour esophageal aspiration study, in which 2-hourly aliquots were measured for acid, pepsin, conjugated and unconjugated bile acids, and trypsin. After conversion to a 45 cm Roux-en-Y gastroenterostomy, symptom scoring and endoscopy were repeated at 6 to 12 months in all eight patients. Pepsin, acid, and unconjugated bile acids were seldom present in esophageal aspirates. Conjugated bile acids in concentrations up to 30 mmol/L and trypsin up to 428 micrograms/ml were found in cases of severe esophagitis, mostly during nocturnal rest. Esophagitis, heartburn, regurgitation, and bilious vomiting were eradicated by Roux-en-Y conversion, but other postgastrectomy symptoms (early satiety, dumping, epigastric pain, and diarrhea) were largely unchanged. Postgastrectomy esophagitis resistant to medical therapy seems likely to be caused by nocturnal exposure to trypsin and conjugated bile acids; it is well controlled by a 45 cm Roux-en-Y conversion.

Entities:  

Mesh:

Year:  1992        PMID: 1728072

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Early and late results of the acid suppression and duodenal diversion operation in patients with barrett's esophagus: analysis of 210 cases.

Authors:  Attila Csendes; Patricio Burdiles; Italo Braghetto; Owen Korn; Juan Carlos Díaz; Jorge Rojas
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

2.  Chromoendoscopic evaluation of gastric mucosa after partial gastrectomy by use of modified endoscopic Congo red test.

Authors:  Ervin Tóth; Kristina Sjölund; Henrik Thorlacius
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

3.  Analysis and suppression of DNA polymerase pauses associated with a trinucleotide consensus.

Authors:  D S Mytelka; M J Chamberlin
Journal:  Nucleic Acids Res       Date:  1996-07-15       Impact factor: 16.971

4.  Reflux esophagitis and marginal ulcer after pancreaticoduodenectomy.

Authors:  Jin-Ming Wu; Meng-Kun Tsai; Rey-Heng Hu; Kin-Jen Chang; Po-Huang Lee; Yu-Wen Tien
Journal:  J Gastrointest Surg       Date:  2011-02-24       Impact factor: 3.452

5.  Fluorescence energy transfer dye-labeled primers for DNA sequencing and analysis.

Authors:  J Ju; C Ruan; C W Fuller; A N Glazer; R A Mathies
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  Trypsin activity and bile acid concentrations in the esophagus after distal gastrectomy.

Authors:  Koji Kono; Akihiro Takahashi; Hidemitsu Sugai; Hidehiko Iizuka; Hideki Fujii
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

7.  Incorporation of dITP or 7-deaza dGTP during PCR improves sequencing of the product.

Authors:  H Dierick; M Stul; W De Kelver; P Marynen; J J Cassiman
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

8.  [Billroth I hemigastrectomy in complicated recurrent ulcer after selective proximal vagotomy].

Authors:  G Arlt; C Peiper; G Winkeltau; V Schumpelick
Journal:  Langenbecks Arch Chir       Date:  1993

Review 9.  Acid and the esophagus.

Authors:  D M McCarthy
Journal:  Yale J Biol Med       Date:  1999 Mar-Jun

10.  Outcomes of endoscopic submucosal dissection for gastroesophageal reflux disease (ESD-G) for medication-refractory gastroesophageal reflux disease: 35 cases underwent ESD-G including 15 cases followed more than 5 years.

Authors:  Kazuhiro Ota; Toshihisa Takeuchi; Yuichi Kojima; Noriaki Sugawara; Shinya Nishida; Taro Iwatsubo; Shimpei Kawaguchi; Satoshi Harada; Satoshi Tokioka; Kazuhide Higuchi
Journal:  BMC Gastroenterol       Date:  2021-11-18       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.